Bristol Myers Squibb

#MEDIA: Today, we announced the expansion of Standing in the Gaap, marking 10 years of work to address gaps and barriers in multiple myeloma care—including plans to launch one of the largest multiple myeloma surveys in the U.S. bit.ly/4tizSRU

#MEDIA: We’re showcasing full Phase 3 SCOUT‑HCM results at #ACC26, highlighting a potential treatment option for adolescents with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Learn more about the data: bit.ly/4theMDz

MEDIA: At this year’s #SIRS2026, we’re presenting abstracts from our neuroscience portfolio, including new #schizophrenia data. Learn more here: bit.ly/4uUgEDM

@Invisible_one19 @Invisible_one19, Thanks for contacting us. We will send you a direct message. Please ensure you follow us.

Hey @BMSNews @Pfizer, your "Eliquis 360 Support" claims to help the underinsured. A human with a 9% EF and an active blood clot in their heart is being crushed by costs because they only have Medicare A&B. This isn't just a prescription; it's a life-line to prevent a stroke. Will you reach out publicly to facebook.com/newgrandma2012 and honor your "patient access" promises? or will you just be Big Pharma #Eliquis #StrokePrevention #BigPharma #DoTheRightThing gofundme.com/f/support-rand…

#MEDIA: At #ACC26 we’re presenting new clinical and real-world insights in symptomatic obstructive hypertrophic cardiomyopathy (oHCM). These data build on our research and highlight outcomes across diverse patient populations: bit.ly/4bqZMwV

#MEDIA: The @US_FDA and the European Commission approved immunotherapy-based treatment combinations for classical #HodgkinLymphoma in certain adult and pediatric patients. bit.ly/4duE2S8

#MEDIA: Announcing positive topline results from a Phase 3 trial evaluating our investigational CELMoD agent for adult patients with relapsed or refractory #MultipleMyeloma. bit.ly/3PvQpTW

#MEDIA: The @US_FDA approved our treatment for active psoriatic arthritis (PsA), bringing a new option for adults living with the condition. Learn more: bit.ly/40P53YR

VP and Head of Global Market Access, Cell Therapy Phung Osborn is a true leader working to increase patient access to cell therapies. A long-time advocate focused on overcoming barriers to care, we’re thrilled to celebrate Phung as our BMS @PhRMA 2026 #WorkingforCures Champion.

Our Chairman and CEO Chris Boerner rang the @NYSE #ClosingBell alongside colleagues, underscoring our shared commitment to discovering, developing and delivering medicines that address serious diseases and improve patients’ lives around the world. #OneBMS

#MEDIA: The @US_FDA accepted our New Drug Application and granted Breakthrough Therapy Designation to our investigational treatment for adult patients with relapsed or refractory multiple myeloma. bit.ly/4rTJWQL

#Media: Announcing that we will be an inaugural partner to @LS_Cares in support of its national campaign to advance health equity and fight food insecurity. bit.ly/3MmwPsi

@HolyMol64145173 @HolyMol64145173 , thank you for letting us know. Please follow our handle so we can send you a direct message.

@ricfink @POTUS @realDonaldTrump @WellcarePlans @bmsnews @mcuban @GoodRx @cvs Stop taking Eliquis!! Main side effect is brain bleed which will cause a stroke!!! Happened to my father. Please get off it now

.@POTUS @realDonaldTrump @WellcarePlans @bmsnews @mcuban @GoodRX @CVS Yesterday at CVS, I paid $622.15 for 3mo of the blood thinner Eliquis (apixiban). I'm retired, on SocSecurity, THIS IS outrageous!! Do I have insurance? YES! I have Medicare Part-D through Wellcare, and THIS is what this med costs WITH insurance!!! GoodRX's 'discount' price was even WORSE! This this America? What is going on here? I have NO active income, but SocSecurity!!!! Pres Trump, I thought you were bringing drug prices DOWN? Did this one slip through? Is Bristol Myers Squibb making Kingly Sums of Money on the promise of strokes? "Buy it at our Hard-To-Pay price or You will DIE!" This is insane, and WRONG! At least, let Mark Cuban sell it at a meaningful and real price that is affordable for this senior group of citizens!

@Lisa_Kay_Vee @ricfink @POTUS @realDonaldTrump @WellcarePlans @mcuban @GoodRx @cvs @Lisa_Kay_Vee, thank you for letting us know. Please follow our handle so we can send you a direct message.

@ricfink @POTUS @realDonaldTrump @WellcarePlans @bmsnews @mcuban @GoodRx @cvs My husband got a coupon for eliquis and cost us 10 dollars for a month's supply. He said Google it. Eventually, he switched to Xeralta because of the itching side effect. We pay 50 a month now with uhc health insurance.

#MEDIA: We’re teaming up with a former U.S. professional soccer player–turned–sports broadcaster, who is also a lymphoma patient, to spread awareness about #CARTCellTherapy. Hear more as he discusses his experience publicly for the first time. bit.ly/46fZZjq

#MEDIA: Announcing the launch of a clinician-focused educational campaign developed to highlight unmet needs in cardiovascular and thromboembolic care, as well as the emerging potential of factor XIa (FXIa) research. bit.ly/4bt1YEy

#Media: Announcing that we are teaming up with @Microsoft to help accelerate the early detection of lung cancer using advanced AI-powered radiology technology. bit.ly/4jRQT27 #OneBMS

#MEDIA: Today, we announced positive topline results from our Phase 3 trial evaluating a potential treatment for adolescent patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Read more: bit.ly/3Z7Jp17

@kaushikbasu11 Thanks for contacting us. We will send you a direct message. Please ensure you follow us.

@bmsnews Hi, have not received any direct message. Could you please help us urgently.

@bmsnews Hello! My father has metastatic lung CA with KRAS G12C mutation. We need Krazati, not available in India. Please suggest options to get this medications at a fair price to treat my father. Happy to share his clinical data for any study I return.